IDEXX Asset Turnover vs Operating Income Analysis
IDXX Stock | USD 489.24 5.02 1.02% |
IDEXX Laboratories financial indicator trend analysis is infinitely more than just investigating IDEXX Laboratories recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether IDEXX Laboratories is a good investment. Please check the relationship between IDEXX Laboratories Asset Turnover and its Operating Income accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IDEXX Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.
Asset Turnover vs Operating Income
Asset Turnover vs Operating Income Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of IDEXX Laboratories Asset Turnover account and Operating Income. At this time, the significance of the direction appears to have almost no relationship.
The correlation between IDEXX Laboratories' Asset Turnover and Operating Income is 0.14. Overlapping area represents the amount of variation of Asset Turnover that can explain the historical movement of Operating Income in the same time period over historical financial statements of IDEXX Laboratories, assuming nothing else is changed. The correlation between historical values of IDEXX Laboratories' Asset Turnover and Operating Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Asset Turnover of IDEXX Laboratories are associated (or correlated) with its Operating Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Operating Income has no effect on the direction of Asset Turnover i.e., IDEXX Laboratories' Asset Turnover and Operating Income go up and down completely randomly.
Correlation Coefficient | 0.14 |
Relationship Direction | Positive |
Relationship Strength | Insignificant |
Asset Turnover
The ratio of net sales to average total assets, indicating how efficiently a company uses its assets to generate sales.Operating Income
Operating Income is the amount of profit realized from IDEXX Laboratories operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of IDEXX Laboratories is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Most indicators from IDEXX Laboratories' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into IDEXX Laboratories current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IDEXX Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.At this time, IDEXX Laboratories' Enterprise Value Over EBITDA is fairly stable compared to the past year. Enterprise Value Multiple is likely to rise to 44.60 in 2024, whereas Selling General Administrative is likely to drop slightly above 194 M in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 1.9B | 2.0B | 2.2B | 2.3B | Total Revenue | 3.2B | 3.4B | 3.7B | 3.8B |
IDEXX Laboratories fundamental ratios Correlations
Click cells to compare fundamentals
IDEXX Laboratories Account Relationship Matchups
High Positive Relationship
High Negative Relationship
IDEXX Laboratories fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 1.8B | 2.3B | 2.4B | 2.7B | 3.3B | 3.4B | |
Other Current Liab | 322.9M | 415.6M | 458.9M | 433.7M | 478.7M | 502.6M | |
Total Current Liabilities | 725.3M | 582.8M | 763.6M | 1.2B | 951.5M | 999.1M | |
Total Stockholder Equity | 177.5M | 632.1M | 690.0M | 608.7M | 1.5B | 1.6B | |
Property Plant And Equipment Net | 533.8M | 555.2M | 587.7M | 649.5M | 702.2M | 737.3M | |
Net Debt | 897.3M | 524.6M | 779.2M | 1.2B | 493.9M | 255.9M | |
Retained Earnings | 1.6B | 2.2B | 2.9B | 3.6B | 4.4B | 4.7B | |
Accounts Payable | 72.2M | 74.6M | 116.1M | 110.2M | 110.6M | 116.2M | |
Cash | 90.3M | 383.9M | 144.5M | 112.5M | 453.9M | 476.6M | |
Non Current Assets Total | 1.2B | 1.2B | 1.5B | 1.6B | 1.8B | 1.9B | |
Non Currrent Assets Other | 299.0M | 337.2M | 397.4M | 425.6M | 448.5M | 470.9M | |
Cash And Short Term Investments | 90.3M | 383.9M | 144.5M | 112.5M | 453.9M | 476.6M | |
Net Receivables | 269.3M | 331.4M | 368.3M | 400.6M | 457.4M | 480.3M | |
Common Stock Shares Outstanding | 87.5M | 86.7M | 86.6M | 84.6M | 84.0M | 94.9M | |
Liabilities And Stockholders Equity | 1.8B | 2.3B | 2.4B | 2.7B | 3.3B | 3.4B | |
Inventory | 195.0M | 209.9M | 269.0M | 367.8M | 380.3M | 399.3M | |
Other Current Assets | 125.0M | 137.5M | 173.8M | 220.5M | 203.6M | 213.8M | |
Other Stockholder Equity | (1.4B) | (1.5B) | (2.2B) | (2.9B) | (2.9B) | (2.8B) | |
Total Liab | 1.7B | 1.7B | 1.7B | 2.1B | 1.8B | 1.9B | |
Total Current Assets | 679.6M | 1.1B | 955.7M | 1.1B | 1.5B | 1.6B | |
Non Current Liabilities Total | 929.3M | 1.1B | 983.6M | 902.2M | 823.8M | 865.0M | |
Intangible Assets | 58.5M | 52.5M | 99.0M | 97.7M | 84.5M | 74.5M | |
Short Long Term Debt Total | 987.7M | 908.5M | 923.7M | 1.3B | 947.9M | 995.3M | |
Short Term Debt | 288.8M | 50.0M | 148.5M | 654.0M | 325.0M | 208.6M | |
Property Plant And Equipment Gross | 614.5M | 646.3M | 1.3B | 649.5M | 1.6B | 1.7B | |
Accumulated Other Comprehensive Income | (46.2M) | (53.6M) | (53.5M) | (77.8M) | (71.2M) | (67.6M) | |
Common Stock Total Equity | 10.6M | 10.6M | 10.7M | 10.7M | 12.3M | 9.0M | |
Common Stock | 10.6M | 10.6M | 10.7M | 10.7M | 10.8M | 9.2M | |
Other Assets | 240.2M | 676.7M | 893.9M | 387.5M | 445.6M | 467.9M | |
Treasury Stock | (2.3B) | (2.6B) | (2.8B) | (3.6B) | (3.2B) | (3.1B) | |
Property Plant Equipment | 533.8M | 555.2M | 587.7M | 649.5M | 746.9M | 784.2M | |
Current Deferred Revenue | 41.5M | 42.6M | 40.0M | 37.9M | 37.2M | 25.0M | |
Good Will | 239.7M | 243.3M | 359.3M | 361.8M | 366.0M | 206.0M | |
Other Liab | 162.8M | 220.5M | 208.4M | 106.6M | 122.6M | 83.3M | |
Long Term Debt | 698.9M | 858.5M | 775.2M | 694.4M | 622.9M | 380.8M | |
Net Tangible Assets | (120.7M) | 336.2M | 690.0M | 149.3M | 134.3M | 141.1M | |
Noncontrolling Interest In Consolidated Entity | 264K | 280K | 352K | 707K | 813.1K | 853.7K | |
Retained Earnings Total Equity | 1.6B | 2.2B | 2.9B | 3.6B | 4.1B | 4.3B | |
Long Term Debt Total | 698.9M | 858.5M | 775.2M | 694.4M | 798.5M | 502.0M |
IDEXX Laboratories Investors Sentiment
The influence of IDEXX Laboratories' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in IDEXX. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to IDEXX Laboratories' public news can be used to forecast risks associated with an investment in IDEXX. The trend in average sentiment can be used to explain how an investor holding IDEXX can time the market purely based on public headlines and social activities around IDEXX Laboratories. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
IDEXX Laboratories' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for IDEXX Laboratories' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average IDEXX Laboratories' news discussions. The higher the estimated score, the more favorable is the investor's outlook on IDEXX Laboratories.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards IDEXX Laboratories in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, IDEXX Laboratories' short interest history, or implied volatility extrapolated from IDEXX Laboratories options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IDEXX Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Complementary Tools for IDEXX Stock analysis
When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |
Is IDEXX Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of IDEXX Laboratories. If investors know IDEXX will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about IDEXX Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.121 | Earnings Share 10.08 | Revenue Per Share 44.073 | Quarterly Revenue Growth 0.088 | Return On Assets 0.2283 |
The market value of IDEXX Laboratories is measured differently than its book value, which is the value of IDEXX that is recorded on the company's balance sheet. Investors also form their own opinion of IDEXX Laboratories' value that differs from its market value or its book value, called intrinsic value, which is IDEXX Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IDEXX Laboratories' market value can be influenced by many factors that don't directly affect IDEXX Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IDEXX Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if IDEXX Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IDEXX Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.